查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1466727

STD 检测市场：按类型、按产品类型、按测试设定、按适应症、按最终用户 - 2024-2030 年全球预测

STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Product Type (Instruments, Reagents & Kits), Test Settings, Indication, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年性病检测市场规模为94.4亿美元，预计2024年将达99.7亿美元，2030年将达141.1亿美元，复合年增长率为5.90%。

性行为感染传染病（STD）检测市场由用于识别性行为感染感染（STI）存在的各种医学检测组成。性病检测对于保障个人健康、预防性病传播、便于及时治疗有重要作用。当症状变得明显时，就需要进行性传染病检测，鑑于许多性传染病长期无症状，因此需要将其作为预防性健康措施。检测种类繁多，包括血液检测、尿液检查、拭子检测和体格检测，每种检测都针对特定的感染疾病，如爱滋病毒、披衣菌感染、衣原体、淋病、梅毒和人类乳突病毒 (HPV)。影响性病检测市场的关键成长要素包括公众对性病的认识不断提高、政府和非政府为遏制性病传播所做的努力以及诊断技术的进步。提高准确性、提高可及性以及减少围绕性病检测的耻辱感正在进一步推动市场成长。此外，全球性传染病盛行率不断上升，需要持续需求有效且有效率的检测解决方案。然而，市场面临社会偏见、经济限制、卫生基础设施有限、意识缺乏等挑战，尤其是保守和欠发达地区。透过数位健康平台和性病检测服务的整合，性病检测市场正在出现新的商机，为个人提供谨慎、便利的远端解决方案。可以从单一样本中检测多种性传染病的更全面的多重测试组合的开发和商业化带来了巨大的成长机会。此外，扩展到性传染病高流行的开拓地区，再加上公共卫生措施和教育宣传活动，可以为性传染病检测市场开闢新的途径。

主要市场统计
基准年[2023] 94.4亿美元
预测年份 [2024] 99.7亿美元
预测年份 [2030] 141.1亿美元
复合年增长率（%） 5.90%

类型：STD 检测，越来越多地偏好使用拭子检测，因为它们是非侵入性的

拭子检测对于诊断披衣菌感染、淋病、人类乳突病毒 (HPV) 和疱疹等性传染病至关重要。这些测试是首选，因为它们是非侵入性的，并且允许直接从感染部位（例如尿道、阴道、子宫颈或喉咙）采集样本。血液检测用于诊断B型肝炎和C型肝炎、梅毒、爱滋病毒和单纯疱疹病毒。当怀疑性传染病已进入血液或检查是否有抗体或病原体本身时，就需要进行血液检查。腰椎穿刺对于诊断梅毒和单纯疱疹病毒引起的神经系统感染极为重要。收集脑脊髓液并检测 STD 病原体的存在。由于该测试很复杂，因此需要在医院中在经验丰富的医疗专业人员的指导下进行。尿液检查通常用于诊断披衣菌感染和淋病。简单且非侵入性的检体采集使其特别适合大规模筛检计划和自我管理测试。疑似性病、感染部位、病人舒适度等都会影响性病检测方法的选择。血液检查和腰椎穿刺是侵入性的，但对于检测全身感染疾病或影响神经系统的感染疾病是必要的。拭子检测可以进行特异性部位的诊断，而尿液检查以其简单方便而闻名，适合筛检包括披衣菌感染和淋病在内的感染疾病。

产品类型：大批量测试环境中对高通量设备的需求

性病检测涉及的设备是用于检测和分析引起性病的病原体的设备。包括PCR设备、ELISA读数仪、质谱仪等。测试设备对于进行大规模、高精度测试的实验室至关重要。设备是进行大量测试的大型医疗机构和实验室的首选。儘管初始成本较高，但设备的耐用性和吞吐量能力为大规模业务提供了更高的效率和更低的长期测试成本。试剂和套件是专门用​​于 STD 检测的化学或生物成分，可以与设备结合使用，也可以单独使用，具体取决于检测类型。包括测试程序所需的一切，包括拭子、化学试剂和对照样品。试剂和套件受到各种医疗保健提供者的青睐，从大型实验室到小型诊所和家庭检测服务。测试量弹性，不需要大量投资特定测试所需的设备。这些非常适合有针对性的测试或大型测试设备的使用受到限制的情况。

测试设定：POC测试因方便快速而广受欢迎

性传染病的实验室检测包括从个人身上采集样本（血液、尿液、拭子）并将这些样本送到专门的实验室进行分析。众所周知，这种方法非常准确，可以检测多种性传染病，包括爱滋病毒、梅毒、披衣菌感染和淋病。当需要进行全面检测时，尤其是怀疑无症状性感染者或多种性传染病时，首选实验室检测。 POC 检测呈阳性后，选择实验室检测作为确认检测。照护现场(POC) 测试在患者的办公时间或地点进行，例如在医生检查室或诊所，或在家中使用自我检测检测套组进行。这种方法可以快速提供结果，这对于立即做出治疗决定至关重要。当需要快速获得结果或难以使用测试设施时，POC 测试是合适的。 POC 检测对于高风险族群特别有用，可以增加患者收到检测结果并接受后续治疗的可能性。

适应症：披衣菌感染发病率增加以及对先进检测技术的需求

披衣菌感染是一种非常常见的细菌感染疾病，通常很少或没有症状。特别建议 25 岁以下的性活跃人士、有新伴侣的人或多位性伴侣的人进行检测。基于实验室的核酸增幅检查（NAAT）是首选检测方法。生殖器疱疹主要由 HSV-2 引起，可透过病毒培养测试、PCR 测试和血液抗体测试来诊断。 PCR 检测直接检测病毒，因其准确而受到青睐。由于抗生素抗药性细菌的增加，淋病检测极为重要。除披衣菌感染外，NAAT已成为淋病检测的黄金标准。乙型肝炎（一种影响肝臟的病毒感染疾病）的筛检需要透过血液检测来检测 HBV DNA 水平、表面抗原和抗体。 HIV 检测对于疾病的早期发现和管理至关重要。测试范围从快速抗体测试到抗原抗体组合测试和核酸测试（NAT）。人类乳突病毒（HPV）是最常见的性行为感染，某些菌株可导致子宫颈癌。此检测主要针对女性，检测高危险 HPV DNA 类型。梅毒检测通常从非密螺旋体抗体检测开始，然后透过密螺旋体抗体检测进行确认。传统的 RPR（快速血浆反应素）测试与较新的 EIA（酵素免疫分析）一起广泛使用。

最终用户：由于诊断中心性病检测的使用增加，交货时间更短

诊断中心专门从事各种健康状况的检测和分析，包括性行为感染传染病（STD）。我们为需要全面体检和需要保密的患者提供服务。该细分市场的需求是由易于访问、快速测试时间和先进测试技术的可用性所推动的。患者更喜欢诊断中心进行常规筛检和匿名。这些中心配备了最新的诊断工具，并有专家提供咨询和即时分析。对于不需要住院治疗的患者尤其优选。医院和诊所提供各种医疗服务，包括性病检测。这些医院和诊所对于寻求全面医疗照护（包括性传染病的诊断、治疗和追踪）的个人来说至关重要。该细分市场因其在医疗保健领域的重要作用而获得了巨大的市场占有率。有性传染病症状或需要结合检查进行咨询的患者更喜欢去医院和诊所。这些设施具有全面护理的优势，患者可以在一个地方接受诊断和治疗。这些设施对于应对需要专门咨询的严重或复杂性病病例至关重要。诊断中心正在精简，以提供及时且往往更实惠的检测服务。诊断中心提供专门的治疗，因此您可能需要在医院获得的全面医疗支援。虽然医院和诊所提供全面的护理，但在测试週转时间方面可能无法与诊断中心相提并论。然而，他们在提供详细的患者照护方面表现出色，包括专家的治疗和咨询。

区域洞察

美洲，特别是美国和加拿大，是重视创新和可近性的已开发市场。美国市场的特征是消费者认知度高，并且有主导研发的大公司。最近的专利强调非侵入性测试方法和快速结果。加拿大市场优先考虑可及的医疗保健，透过公共卫生宣传活动和对检测中心的大量投资来提高性传染病的认识和预防。南美洲的性病检测市场仍然强劲，尤其是巴西，由于性病患病率不断上升，政府专注于公共卫生宣传活动和医疗设施的改善，以促进市场扩张。欧洲、中东和非洲的性病检测市场呈现多样化格局。由于完善的医疗保健系统和持续的研究倡议，欧盟 (EU) 国家对先进诊断测试的需求很高。该地区开发创新测试解决方案的官民合作关係正在不断发展。相较之下，中东地区则致力于透过教育宣传活动和基础设施投资来提高公众意识并消除性病检测的文化障碍。儘管由于资源限制，非洲面临着独特的挑战，但它见证了针对其需求的国际援助和创新检测解决方案的增加，创造了一个负担得起且易于获得的性病检测市场，这表明它正在扩大。在医疗基础设施快速扩张、中阶人口不断增长以及政府加强公共卫生的推动下，亚太地区性病检测市场正在快速开拓。中国、印度和澳洲等国家正在透过专注于宣传宣传活动和引进先进的诊断测试技术来促进这一成长。

FPNV定位矩阵

FPNV定位矩阵对于评估STD检测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可对 STD 测试市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析也为此细分市场的竞争特征提供了宝贵的见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.性病检测市场规模及预测是多少？

2.在性病检测市场的预测期内，有哪些产品、细分市场、应用程式和细分市场需要考虑投资？

3.性病检测市场的技术趋势和法规结构是什么？

4.性病检测市场主要厂商的市场占有率为何？

5.进入性病检测市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球性行为感染传染病的发生率和盛行率不断增加
      • 透过教育宣传活动提高对性行为感染传染病的认识
    • 抑制因素
      • 核准性病检测产品的严格监管指南存在问题
    • 机会
      • 性行为感染诊断技术不断进步
      • 增加全国的筛检检测并促进性病检测的采用
    • 任务
      • 与看专科医生相关的社会耻辱
  • 市场区隔分析
    • 类型：STD 检测 拭子检测越来越受欢迎，因为它们是非侵入性的
    • 产品类型：需要用于大容量测试环境的高通量设备
    • 测试设定：优先考虑 POC 测试，因其无与伦比的便利性和速度
    • 适应症：披衣菌感染发病率增加以及对先进检测技术的需求
    • 最终用户：扩大诊断中心性病检测的使用并减少週转时间
  • 市场趋势分析
    • 家用性病检测套组越来越受欢迎，各大公司在美洲都站稳了脚步。
    • 性行为感染的性行为感染力度
    • 诊断解决方案和创新产品的严格法规结构，以促进全部区域的性病检测
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章性病检测市场：依类型

  • 介绍
  • 验血
  • 腰椎穿刺
  • 拭子测试
  • 尿液检查

第七章性病检测市场：依产品类型

  • 介绍
  • 装置
  • 试剂和套件

第八章性病检测市场：依检测设置

  • 介绍
  • 实验室
  • 照护现场

第九章性病检测市场：依适应症分类

  • 介绍
  • 披衣菌感染
  • 生殖器疱疹
  • 淋病
  • B型肝炎
  • HIV爱滋病
  • 人类乳突病毒
  • 梅毒

第 10 章 STD 检测市场：依最终用户分类

  • 介绍
  • 诊断中心
  • 医院/诊所

第十一章 南北美洲性病检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太性病检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲性病检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-69324464D0F2

[195 Pages Report] The STD Testing Market size was estimated at USD 9.44 billion in 2023 and expected to reach USD 9.97 billion in 2024, at a CAGR 5.90% to reach USD 14.11 billion by 2030.

Sexually transmitted disease (STD) testing market comprises various medical examinations used to identify the presence of sexually transmitted infections (STIs). STD testing plays a critical role in ensuring individual health, preventing the spread of STDs, and facilitating timely treatment. The need for STD testing arises when symptoms are apparent and as a preventive health measure, considering that many STDs may remain asymptomatic for prolonged periods. The types of tests conducted vary widely, encompassing blood tests, urine tests, swabs, and physical examinations, each targeting specific infections such as HIV, herpes, chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV). The significant growth factors impacting the STD testing market include increasing awareness about STDs among the general population, governmental and non-governmental efforts to combat the spread of STDs, and advancements in diagnostic technologies. Enhanced accuracy, accessibility, and the declining stigma associated with STD testing have further propelled the market's growth. Additionally, the rising incidence rates of STDs globally necessitate continuous demand for effective and efficient testing solutions. However, the market faces challenges, including social stigma, particularly in conservative and less-developed regions, financial constraints, limited healthcare infrastructure, and lack of awareness. New opportunities in the STD testing market are emerging from integrating digital health platforms with STD testing services, which offer discreet, convenient, and remote solutions for individuals. The development and commercialization of more comprehensive multiplex testing panels, capable of detecting multiple STDs from a single sample, present significant growth venues. Moreover, expanding into underserved regions with high STD prevalence, coupled with public health initiatives and education campaigns, can open new avenues for the STD testing market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.44 billion
Estimated Year [2024] USD 9.97 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 5.90%

Type: Increasing preference for swab tests for STD testing for their non-invasive nature

Swab tests are essential for diagnosing STDs such as chlamydia, gonorrhea, human papillomavirus (HPV), and herpes. These tests are preferred for their non-invasive nature and the ability to collect samples directly from the site of infection, such as the urethra, vagina, cervix, or throat. Blood tests are used to diagnose hepatitis B and C, syphilis, HIV, and herpes simplex virus. They are preferred when an STD is suspected to have entered the bloodstream or to check for the presence of antibodies or the pathogen itself. Lumbar puncture is crucial for diagnosing nervous system infections caused by syphilis or herpes simplex virus. It involves collecting cerebrospinal fluid to detect the presence of the STD pathogen. This procedure is conducted in hospital settings under the guidance of experienced medical professionals due to its complexity. Urine tests are frequently used for diagnosing chlamydia and gonorrhea. They are favored for their ease of sample collection and non-invasive nature, making them especially suitable for large-scale screening programs or self-administered testing. The suspected STD, the site of infection, and patient comfort influence the choice of STD testing method. Blood tests and lumbar punctures are more invasive but necessary for detecting systemic infections and those affecting the nervous system. Swab tests, offering site-specific diagnosis, and urine tests, known for their ease and convenience, are more suited for widespread screening of infections, including chlamydia and gonorrhea.

Product Type: Need for high-throughput instruments for high-volume testing environments

Instruments in STD testing are devices used for the detection and analysis of pathogens responsible for STDs. These include PCR machines, ELISA readers, and mass spectrometers. Instruments are integral in laboratories for conducting large-scale and highly accurate tests. Instruments are preferred by larger health facilities and laboratories that perform high volumes of tests. The upfront cost is higher, while instruments offer greater efficiency and lower long-term costs per test for large-scale operations due to their durability and throughput capabilities. Reagents and kits are chemical or biological components used explicitly for STD testing in conjunction with instruments or standalone, depending on the test type. These include everything necessary for the testing procedure, such as swabs, chemical reagents, and control samples. Reagents and kits are favored by varied healthcare providers, from large laboratories to smaller clinics and at-home testing services. They offer flexibility in testing volume, with no significant investment required in instrumentation for certain tests. These are ideal for targeted testing and situations where access to large laboratory instruments is limited.

Test Settings: Preference for POC tests for their unmatched convenience and speed

Laboratory testing for STDs involves collecting samples (blood, urine, or swabs) from individuals and sending these samples to a specialized laboratory for analysis. This method is known for its accuracy and the ability to test for several types of STDs, including HIV, syphilis, chlamydia, gonorrhea, and others. Laboratory testing is preferred when comprehensive testing is required, especially for asymptomatic infections or when multiple STDs are suspected. It is chosen for confirmatory testing following a positive POC test. Point-of-care (POC) testing is conducted at the time and place of patient care, such as in a doctor's office, a clinic, or even at home with self-testing kits. This method provides rapid results, which is crucial for immediate treatment decisions. POC testing is preferred in settings where rapid results are necessary or when access to laboratory facilities is unavailable. It is particularly useful for high-risk populations and to increase the chance of patients receiving their results and subsequent treatment.

Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies

Chlamydia is a highly common bacterial infection that often presents with few or no symptoms. Testing is particularly recommended for sexually active individuals under 25 and those with new or multiple partners. Laboratory-based nucleic acid amplification tests (NAATs) are the preferred method for detection. Genital Herpes, primarily caused by HSV-2, is diagnosed through viral culture tests, PCR tests, and blood tests for antibodies. The preference leans towards PCR testing for its accuracy in detecting the virus directly. Gonorrhea testing is crucial due to the bacteria's growing antibiotic resistance. In addition to Chlamydia, NAATs serve as the gold standard for gonorrhea detection. For Hepatitis B, a viral infection affecting the liver, screening involves blood tests to detect HBV DNA levels, surface antigens, and antibodies. HIV testing is critical for early detection and management of the disease. Tests range from rapid antibody tests to combined antigen/antibody tests and nucleic acid tests (NATs). Human papillomavirus (HPV) is the most common sexually transmitted infection, with certain strains causing cervical cancer. Testing mainly targets women and involves detecting high-risk HPV DNA types. Syphilis testing typically involves initial non-treponemal antibody testing followed by confirmatory treponemal antibody tests. Traditional RPR (Rapid Plasma Reagin) tests are widely used with newer EIA (Enzyme Immunoassays).

End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time

Diagnostic centers specialize in the detection and analysis of various health conditions, including sexually transmitted diseases (STDs). They cater to patients requiring comprehensive screening and those who seek confidentiality. The demand in this segment is driven by their accessibility, quick turnaround time, and the availability of advanced testing technologies. Patients prefer diagnostic centers for routine screenings or when seeking anonymity. These centers are provided with the latest diagnostic tools and have specialists to offer counseling and immediate analysis. They are particularly favored by individuals not requiring hospital-based interventions. Hospitals and clinics provide various medical services, including STD testing. They are essential for individuals seeking comprehensive medical care, including diagnosis, treatment, and follow-up for STDs. This segment captures a significant market share due to its integral role in health care. Patients with symptoms of STDs or those in need of consultation alongside testing prefer hospitals and clinics. These facilities offer the advantage of integrated care, where patients can receive both diagnosis and treatment in one location. They are vital for handling more severe or complex STD cases that require specialized medical attention. Diagnostic centers are streamlined for timely and often more affordable testing services. They offer specialized care and may need more comprehensive medical support, which is available in hospitals. While hospitals and clinics provide comprehensive care, they may not match the diagnostic centers in terms of testing turnaround times. However, they prevail in offering detailed patient care, including treatment and counseling by specialists.

Regional Insights

The Americas, particularly the United States and Canada, represent a developed market with a strong emphasis on innovation and accessibility. In the United States, the market is defined by high consumer awareness and the presence of major companies leading research and development. Recent patents emphasize non-invasive testing methods and rapid results. Canada's market prioritizes accessible healthcare, with significant investments in public health campaigns and testing centers to increase STD awareness and prevention. The STD testing market in South America is progressing steadily, with Brazil carrying potential due to rising STD prevalence, governmental focus on public health campaigns, and improving healthcare facilities are instrumental in the market's expansion. The EMEA region presents a diverse landscape in the STD testing market. European Union countries exhibit a high demand for advanced diagnostic tests, driven by well-established healthcare systems and ongoing research initiatives. The region has witnessed growth in public-private partnerships for developing innovative testing solutions. In contrast, the Middle East focuses on increasing public awareness and breaking cultural barriers to STD testing with investments in educational campaigns and infrastructure. Africa faces unique challenges due to resource constraints while witnessing a rise in international aid and innovative testing solutions tailored to its needs, indicating a growing market for affordable and accessible STD testing. The APAC region is experiencing rapid development in the STD testing market, driven by rapidly expanding healthcare infrastructure, a growing middle-class population, and increased government initiatives toward public health. Countries such as China, India, and Australia are promoting this growth, focusing on awareness campaigns and integrating advanced technologies for diagnostic testing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the STD Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the STD Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuquik by AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., ARCpoint Labs, Becton, Dickinson and Company, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., bioMerieux SA, BioReference Health, LLC by OPKO HEALTH, INC., Danaher Corporation, Daye Limited, Everlywell, Inc., F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Grifols, S.A., Hologic, Inc., JAL Medical by OK Biotech Co. Ltd., Laboratory Corporation of America Holdings, LifeCell, Lorne Laboratories Limited by Calibre Scientific, Meridian Bioscience Inc. by SD Biosensor, Inc., OraSure Technologies, Inc., Personalabs, Qiagen N.V., Quest Diagnostics, Inc., Randox Laboratories Ltd., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Viatris Inc., and Wondfo Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Blood Tests
    • Lumbar Puncture
    • Swab Tests
    • Urine Tests
  • Product Type
    • Instruments
    • Reagents & Kits
  • Test Settings
    • Laboratory
    • Point of Care
  • Indication
    • Chlamydia
    • Genital Herpes
    • Gonorrhea
    • Hepatitis B
    • HIV/AIDS
    • Human Papillomavirus
    • Syphilis
  • End-user
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the STD Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the STD Testing Market?

3. What are the technology trends and regulatory frameworks in the STD Testing Market?

4. What is the market share of the leading vendors in the STD Testing Market?

5. Which modes and strategic moves are suitable for entering the STD Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
      • 5.1.1.2. Increasing awareness about STDs through education campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technical advancements in STD disease diagnostics
      • 5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for swab tests for STD testing for their non-invasive nature
    • 5.2.2. Product Type: Need for high-throughput instruments for high-volume testing environments
    • 5.2.3. Test Settings: Preference for POC tests for their unmatched convenience and speed
    • 5.2.4. Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies
    • 5.2.5. End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time
  • 5.3. Market Trend Analysis
    • 5.3.1. Growing popularity of at-home STD testing kits, coupled with a strong foothold of major companies across the Americas region
    • 5.3.2. Expanding government awareness initiatives against STDs due to the prevalence of STDs across the APAC region
    • 5.3.3. Stringent regulatory frameworks for diagnostic solutions and innovative product offerings for facilitating accessible STD testing across the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. STD Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Lumbar Puncture
  • 6.4. Swab Tests
  • 6.5. Urine Tests

7. STD Testing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Kits

8. STD Testing Market, by Test Settings

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. Point of Care

9. STD Testing Market, by Indication

  • 9.1. Introduction
  • 9.2. Chlamydia
  • 9.3. Genital Herpes
  • 9.4. Gonorrhea
  • 9.5. Hepatitis B
  • 9.6. HIV/AIDS
  • 9.7. Human Papillomavirus
  • 9.8. Syphilis

10. STD Testing Market, by End-user

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals & Clinics

11. Americas STD Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific STD Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa STD Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Alliance Advances Self-Test Solutions for Sexually Transmitted Diseases
    • 14.3.2. imaware Expands its Portfolio through binx health's Consumer Division Purchase
    • 14.3.3. FDA Approves Advanced At-home Chlamydia and Gonorrhea Test
    • 14.3.4. British Startup Launches Tampon That Offers STI Screening
    • 14.3.5. iHealth Launches Home Collection Kit for STD Testing
    • 14.3.6. Aptitude Medical Systems' Innovative Approach to Combat Sexually Transmitted Infections (STIs)
    • 14.3.7. LifeCell International Revolutionizes STD and HPV Screening with At-Home Test Kits
    • 14.3.8. Breakthrough 20-Minute Test for Gonorrhea and Chlamydia by Linear Diagnostics
    • 14.3.9. US BioTek's Innovative At-Home Testing Solutions
    • 14.3.10. Visby Medical Achieves FDA Clearance for Advanced Sexual Health Diagnostic Tool
    • 14.3.11. Mylab Launches a Range of Rapid Tests for STDs
    • 14.3.12. Strategic Partnership between Maternova and MedMira Enhances Global Access to Rapid Diagnostic Tests for Infectious Diseases
    • 14.3.13. Innovative Partnership Tackles STI Spike Among Gen Z with At-Home Testing Solutions
    • 14.3.14. Meridian Bioscience Joins Forces with SD Biosensor and SJL Partners

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. STD TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL STD TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 378. QATAR STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 384. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 385. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 386. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 387. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 388. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA STD